Soluble HLA-G and control of angiogenesis

Journal of Reproductive Immunology

Volumn 76, Issue 1-2, 2007, Pages 17-22

  Le Bouteiller, Philippe ^a,b   Fons, Pierre ^c   Herault, Jean Pascal ^c   Bono, Françoise ^c   Chabot, Sophie ^a,b   Cartwright, Judith E ^d   Bensussan, Armand ^e  

^a INSERM   (France)

^b UNIVERSITÉ DE TOULOUSE   (France)

^c SANOFI   (France)

^d ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^e UNIVERSITÉ PARIS EST CRÉTEIL   (France)

Author keywords

Endothelial cell; Pregnancy; Soluble HLA G

Indexed keywords

BETA 2 MICROGLOBULIN; CD160 RECEPTOR; CD1D ANTIGEN; CELL SURFACE RECEPTOR; FIBROBLAST GROWTH FACTOR 2; HLA G ANTIGEN; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL CELL; APOPTOSIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CORNEA; ENDOTHELIUM CELL; FETOPLACENTAL UNIT; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; RABBIT; REVIEW;

ANGIOGENESIS MODULATING AGENTS; ANIMALS; ANTIGENS, CD; ENDOTHELIAL CELLS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; PLACENTA; PREGNANCY; RECEPTORS, IMMUNOLOGIC; TROPHOBLASTS; UTERUS;

EID: 34447522965     PISSN: 01650378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jri.2007.03.007     Document Type: Review

References (45)

1. Agrawal S., Marquet J., Freeman G.J., Tawab A., Le Bouteiller P., Roth P., Bolton W., Ogg G., Boumsell L., and Bensussan A. Cutting edge: MHC class I triggering by a novel cell surface ligand costimulates proliferation of activated human T cells. J. Immunol. 162 (1999) 1223-1226
2. Anumantha A., Bensussan A., Boumsell L., Christ A., Blumberg R., Voss S., Patel A., Robertson M., Nadler L., and Freeman G. Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J. Immunol. 161 (1998) 2780-2790
3. Ashton S.V., Whitley G.S., Dash P.R., Wareing M., Crocker I.P., Baker P.N., and Cartwright J.E. Uterine spiral artery remodeling involves endothelial apoptosis induced by extravillous trophoblasts through Fas/FasL interactions. Arterioscler Thromb. Vasc. Biol. 25 (2005) 102-108
4. Barakonyi A., Rabot M., Marie-Cardine A., Aguerre-Girr M., Polgar B., Schiavon V., Bensussan A., and Le Bouteiller P. Cutting edge: engagement of CD160 by its HLA-C physiological ligand triggers a unique cytokine profile secretion in the cytotoxic peripheral blood NK cell subset. J. Immunol. 173 (2004) 5349-5354
5. Binetruy-Tournaire R., Demangel C., Malavaud B., Vassy R., Rouyre S., Kraemer M., Plouet J., Derbin C., Perret G., and Mazie J.C. Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis. EMBO J. 19 (2000) 1525-1533
6. Borzychowski A.M., Sargent I.L., and Redman C.W. Inflammation and pre-eclampsia. Semin. Fetal Neonatal Med. 11 (2006) 309-316
7. Bulla R., Villa A., Bossi F., Cassetti A., Radillo O., Spessotto P., De Seta F., Guaschino S., and Tedesco F. VE-cadherin is a critical molecule for trophoblast-endothelial cell interaction in decidual spiral arteries. Exp. Cell Res. 303 (2005) 101-113
8. Bulmer J., and Lash G. Human uterine natural killer cells: a reappraisal. Mol. Immunol. 42 (2005) 511-521
9. Cartwright J.E., and Wareing M. An in vitro model of trophoblast invasion of spiral arteries. Methods Mol. Med. 122 (2006) 59-74
10. Chaouat G., Lédée-Bataille N., and Dubanchet S. Immunological similarities between implantation and pre-eclampsia. Am. J. Reprod. Immunol. 53 (2005) 222-229
11. Colbern G.T., Chiang M.H., and Main E.K. Expression of the nonclassic histocompatibility antigen HLA-G by preeclamptic placenta. Am. J. Obstet. Gynecol. 170 (1994) 1244-1250
12. Dash P.R., Cartwright J.E., Baker P.N., Johnstone A.P., and Whitley G.S. Nitric oxide protects human extravillous trophoblast cells from apoptosis by a cyclic GMP-dependent mechanism and independently of caspase 3 nitrosylation. Exp. Cell Res. 287 (2003) 314-324
13. Dorling A., Monk N., and Lechler R. HLA-G inhibits the transendothelial migration of human NK cells. Eur. J. Immunol. 30 (2000) 586-593
14. Fickling S.A., Tooze J.A., and Whitley G.S. Characterization of human umbilical vein endothelial cell lines produced by transfection with the early region of SV40. Exp. Cell Res. 201 (1992) 517-521
15. Fons P., Chabot S., Cartwright J.E., Lenfant F., L'Faqihi F., Giustiniani J., Herault J.P., Gueguen G., Bono F., Savi P., Aguerre-Girr M., Fournel S., Malecaze F., Bensussan A., Plouet J., and Le Bouteiller P. Soluble HLA-G1 inhibits angiogenesis through an apoptotic pathway and by direct binding to CD160 receptor expressed by endothelial cells. Blood 108 (2006) 2608-2615
16. Fournel S., Aguerre-Girr M., Campan A., Salauze L., Berrebi A., Lone Y., Lenfant F., and Le Bouteiller P. Soluble HLA-G: purification from eucaryotic transfected cells and detection by a specific ELISA. Am. J. Reprod. Immunol. 42 (1999) 22-29
17. Fujii T., Ishitani A., and Geraghty D.E. A soluble form of the HLA-G antigen is encoded by a messenger ribonucleic acid containing intron 4. J. Immunol. 153 (1994) 5516-5524
18. Goldman-Wohl D., Ariel I., Greenfield C., Hochner-Celnikier D., Cross J., Fisher S., and Yagel S. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol. Hum. Reprod. 6 (2000) 88-95
19. Hanna J., Goldman-Wohl D., Hamani Y., Avraham I., Greenfield C., Natanson-Yaron S., Prus D., Cohen-Daniel L., Arnon T.I., Manaster I., Gazit R., Yutkin V., Benharroch D., Porgador A., Keshet E., Yagel S., and Mandelboim O. Decidual NK cells regulate key developmental processes at the human fetal-maternal interface. Nat. Med. 12 (2006) 991-992
20. Hara N., Fujii T., Yamashita T., Kozuma S., Okai T., and Taketani Y. Altered expression of human leukocyte antigen G (HLA-G) on extravillous trophoblasts in preeclampsia: immunohistological demonstration with anti-HLA-G specific antibody '87G' and anti-cytokeratin antibody 'CAM5. 2'. Am. J. Reprod. Immunol. 36 (1996) 349-358
21. Hunt J.S., Petroff M.G., McIntire R.H., and Ober C. HLA-G and immune tolerance in pregnancy. FASEB J. 19 (2005) 681-693
22. Hunt J.S. Stranger in a strange land. Immunol. Rev. 213 (2006) 36-47
23. Ishitani A., Sageshima N., Lee N., Dorofeeva N., Hatake K., Marquardt H., and Geraghty D. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171 (2003) 1376-1384
24. Ishitani A., Sageshima N., and Hatake K. The involvement of HLA-E and -F in pregnancy. J. Reprod. Immunol. 69 (2006) 101-113
25. Le Bouteiller P., Barakonyi A., Giustiniani J., Lenfant F., Marie-Cardine A., Aguerre-Girr M., Rabot M., Hilgert I., Mami-Chouaib F., Tabiasco J., Boumsell L., and Bensussan A. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16963-16968
26. Le Bouteiller P., Pizzato N., Barakonyi A., and Solier C. HLA-G, pre-eclampsia, immunity and vascular events. J. Reprod. Immunol. 59 (2003) 219-234
27. Le Bouteiller P., Rodriguez A.M., Mallet V., Girr M., Guillaudeux T., and Lenfant F. Placental expression of HLA class I genes. Am. J. Reprod. Immunol. 35 (1996) 216-225
28. Le Bouteiller P., Solier C., Pröll J., Aguerre-Girr M., Fournel S., and Lenfant F. Placental HLA-G protein expression in vivo: where and what for?. Hum. Reprod. Update 5 (1999) 223-233
29. Le Bouteiller P., and Tabiasco J. Killers become builders during pregnancy. Nat. Med. 12 (2006) 991-992
30. Lim K.H., Zhou Y., Janatpour M., McMaster M., Bass K., Chun S.H., and Fisher S.J. Human cytotrophoblast differentiation/invasion is abnormal in pre-eclampsia. Am. J. Pathol. 151 (1997) 1809-1818
31. Loke Y.W., and King A. Human Implantation: Cell Biology and Immunology (1995), Cambridge University Press, Cambridge 299 pp.
32. Maeda M., Carpetino C., Russell R., Dasanjh J., Veinotte L., Ohta H., Yamamura T., Tan R., and Takei F. Murine CD160, Ig-like receptor on NK cells and NKT cells, recognizes classical and non classical MHC class I and regulates NK cell activation. J. Immunol. 175 (2005) 4426-4432
33. Maynard S.E., Min J.Y., Merchan J., Lim K.H., Li J., Mondal S., Libermann T.A., Morgan J.P., Sellke F.W., Stillman I.E., Epstein F.H., Sukhatme V.P., and Karumanchi S.A. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111 (2003) 649-658
34. Menier C., Rabreau M., Challier J.C., Le Discorde M., Carosella E.D., and Rouas-Freiss N. Erythroblasts secrete the nonclassical HLA-G molecule from primitive to definitive hematopoiesis. Blood 104 (2004) 3153-3160
35. Moffett-King A. Natural killer cells and pregnancy. Nat. Rev. Immunol. 2 (2002) 656-663
36. Moffett-King A., Entrican G., Ellis S., Hutchinson J., and Bainbridge D. Natural killer cells and reproduction. Trends Immunol. 23 (2002) 332-333
37. Moffett A., and Loke Y.W. Immunology of placentation in eutherian mammals. Nat. Rev. Immunol. 6 (2006) 584-594
38. O'Brien M., McCarthy T., Jenkins D., Paul P., Dausset J., Carosella E.D., and Moreau P. Altered HLA-G transcription in pre-eclampsia is associated with allele specific inheritance: possible role of the HLA-G gene in susceptibility to the disease. Cell. Mol. Life Sci. 58 (2001) 1943-1949
39. Pijnenborg R., Vercruysse L., and Hanssens M. The uterine spiral arteries in human pregnancy: facts and controversies. Placenta 27 (2006) 939-958
40. Red-Horse K., Rivera J., Schanz A., Zhou Y., Winn V., Kapidzic M., Maltepe E., Okazaki K., Kochman R., Vo K.C., Giudice L., Erlebacher A., McCune J.M., Stoddart C.A., and Fisher S.J. Cytotrophoblast induction of arterial apoptosis and lymphangiogenesis in an in vivo model of human placentation. J. Clin. Invest. 116 (2006) 2643-2652
41. Redman C.W., and Sargent I.L. Latest advances in understanding preeclampsia. Science 308 (2005) 1592-1594
42. Tsujimura K., Obata Y., Matsudaira Y., Nishida K., Akatsuka Y., Ito Y., Demachi-Okamura A., Kuzushima K., and Takahashi T. Characterization of murine CD160(+) CD8(+) T lymphocytes. Immunol. Lett. 106 (2006) 48-56
43. Yie S.M., Li L.H., Li Y.M., and Librach C. HLA-G protein concentrations in maternal serum and placental tissue are decreased in preeclampsia. Am. J. Obstet. Gynecol. 191 (2004) 525-529
44. Yie S.M., Taylor R.N., and Librach C. Low plasma HLA-G protein concentrations in early gestation indicate the development of preeclampsia later in pregnancy. Am. J. Obstet. Gynecol. 193 (2005) 204-208
45. Zeng M.H., Fang C.Y., Wang S.S., Zhu M., Xie L., Li R., Wang L., Wu X.W., and Chen S. A Study of Soluble HLA-G(1) protecting porcine endothelial cells against human natural killer cell-mediated cytotoxicity. Transplant. Proc. 38 (2006) 3312-3314